Google+ Badge

Sunday, May 3, 2015

Cancer Research: Comprehensive look at brain cancer treatments ♦ gastrointestinal tumors at higher risk of other cancer ♦ New potential melanoma drug target discovered

Comprehensive look at brain cancer treatments A comprehensive genetic review of treatment strategies for glioblastoma brain tumors covers how these highly invasive and almost-always-deadly brain cancers may be treated, reviews the continuing challenges faced by researchers and presents the hope for better treatments by harnessing the power of the human genome.
Patients with gastrointestinal tumors at higher risk of other cancers The first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers has been conducted by researchers. The results indicate that one in 5.8 patients with GIST will develop additional malignancies.
New potential melanoma drug target discovered A new treatment for melanoma could be on the horizon, thanks to a recent finding. In the study, authors found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
Link between inherited genetic variations, outcomes of non-small cell lung cancer patients discovered Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Patients diagnosed with NSCLC have a poor prognosis, with a 5-year survival rate of only 16 percent. Researchers hope to improve NSCLC patient survival with the results of a study that found that inherited genetic variations in interleukin genes are associated with improved patient survival.
Lifetime intense physical activity may lower risk for non-Hodgkin lymphoma Performing vigorous physical activity over one's lifetime may lower risk for non-Hodgkin lymphoma. Because not much is known about what causes non-Hodgkin lymphoma, identifying risk factors is particularly important for the prevention and control of this cancer.

No comments:

Post a Comment